![](/assets/artwork/1x1-42817eea7ade52607a760cbee00d1495.gif)
1 hr 16 min
![](/assets/artwork/1x1-42817eea7ade52607a760cbee00d1495.gif)
Oncology Today with Dr Neil Love: Understanding the Risk of Recurrence and Related Management for Patients with Localized HER2-Positive Breast Cancer Breast Cancer Update
-
- Science
Dr Adam M Brufsky from UPMC Hillman Cancer Center in Pittsburgh summarizes the history of and modern advances in treating localized HER2-positive breast cancers, including strategies for monitoring and managing treatment-related toxicities.
Dr Adam M Brufsky from UPMC Hillman Cancer Center in Pittsburgh summarizes the history of and modern advances in treating localized HER2-positive breast cancers, including strategies for monitoring and managing treatment-related toxicities.
1 hr 16 min